Investors

Events and Presentations

Analyst Coverage

Corporate Governance

Publication Archive

Investor Contacts & Alerts

News Releases

Jan 17, 2018

Evofem Announces Closing Of Merger With Neothetics

Commences Trading on NASDAQ Capital Market on Thursday, January 18, 2018 Under Ticker Symbol "EVFM"
Nov 16, 2017

Form S-4 Filed with SEC
Oct 17, 2017

Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company
Jul 27, 2017

Evofem Biosciences Announces First Patient Enrolled in a Phase 3 Clinical Trial of AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) for Prevention of Pregnancy
Jun 29, 2017

AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) Receives "Qualified Infectious Disease Product" (QIDP) Designation from the FDA

Show per page